Galapagos NV
GLPG
#4563
Rank
A$3.17 B
Marketcap
A$47.56
Share price
-0.57%
Change (1 day)
12.77%
Change (1 year)

Galapagos NV (GLPG) - Total debt

Total debt on the balance sheet as of September 2025 : A$13.25 Million

According to Galapagos NV's latest financial reports the company's total debt is A$13.25 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Galapagos NV - Total debt on balance sheet (from 2008 to 2025)

Total debt by year

Year Total debt Change
2024-12-31A$19.61 M25.95%
2023-12-31A$15.57 M-54.9%
2022-12-31A$34.52 M-17.72%
2021-12-31A$41.95 M-10.89%
2020-12-31A$47.08 M15.93%
2019-12-31A$40.61 M
2018-12-31N/A-100%
2017-12-31A$0.01 M-84.95%
2016-12-31A$0.09 M-46.74%
2015-12-31A$0.17 M-30.45%
2014-12-31A$0.24 M-59.21%
2013-12-31A$0.6 M18.03%
2012-12-31A$0.51 M-53.54%
2011-12-31A$1.1 M-31.94%
2010-12-31A$1.63 M-31.12%
2009-12-31A$2.36 M-29.16%
2008-12-31A$3.34 M-54.2%
2007-12-31A$7.29 M-43.89%
2006-12-31A$13 M0.79%
2005-12-31A$12.89 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
AstraZeneca
AZN
A$49.12 B 370,540.02%๐Ÿ‡ฌ๐Ÿ‡ง UK
Johnson & Johnson
JNJ
A$68.94 B 520,047.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$38.43 B 289,889.02%๐Ÿ‡ซ๐Ÿ‡ท France
AbbVie
ABBV
A$103.49 B 780,695.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Fortress Biotech
FBIO
A$0.10 B 686.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$19.48 B 146,886.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$25.70 B 193,818.15%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
A$35.92 B 270,928.81%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
A$62.28 B 469,833.20%๐Ÿ‡บ๐Ÿ‡ธ USA